ChitoTech (Keifiat Tolid Takapoo) Introduction
ChitoTech was founded as a research center with the main aim of exploring marine biopolymers’ properties and the results of studies shed light on their extensive potential in medical products.
The manufacturing site was established in 2004 and focused on producing advanced wound care and novel hemostatic products. Currently, ChitoTech manufactures a wide range of over 60 products specifically designed for wound care management and hemostasis, antiseptic solution, hygiene products, first aid boxes and adhesive dressings. The novelty of what ChitoTech did can be summarized in using natural biopolymers in a wide range of bioactive, seamless wound care products useful for acute and chronic wounds for the first time.
ChitoTech Founder Introduction
Dr. Soheila S. Kordestani, the founder of ChitoTech is a protein chemist, who graduated from Leeds University in 1989 with PhD degree in biochemistry and graduated from the University of Birmingham Medical School in 1991 with specialist degree. She has been working in the field of wound healing for the last 25 years. She was a faculty member and a lecturer in the Biomedical Engineering Department at the Amirkabir University of Technology, Tehran, Iran, and her primary focus was teaching on the topic of role of biomaterials in wound healing and, aimed at graduate students.
Certificates & Publications
ChitoTech products were administered to countless individuals across the globe. The conclusion of almost two decades of dedicated efforts to gather the findings obtained from the utilization of cutting-edge wound management techniques on a significant population has been gathered and featured in “Atlas of Wound Healing: A Tissue Regeneration Approach”  published by Elsevier in 2019. In addition, 23 articles concerning early researches and clinical studies on ChitoTech products have been published. ChitoTech products are protected by 29 US, European (UK, Germany, Denmark, France and Ireland) and national patents. Furthermore, all the products have the approval of Iranian Ministry of Health, CE mark and are in compliance with ISO 13485, ISO 14001 and GMP. ChitoTech was awarded the technology award from Global Health & Pharma for four consecutive years of 2018-2021 as Leading Providers of Wound Care Solutions in Western Asia.
Distribution, Export & Technology Transfer
“ChitoTech’s products are distributed and sold in hospitals all over Iran, as well as being exported to various countries such as Italy, Poland, Greece, the Philippines, Malaysia, Indonesia, Turkey, and Syria.” Furthermore, the technology of producing wound healing gel transferred to Malaysia. Based on our innovative technology, we are planning to become a global healthcare group specializing in the production and distribution of medical devices that extends beyond Iran and Asia covering the entire globe.